Separate names with a comma.
Sep 07, 2016 OTC Disclosure & News Service Spectral Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in...
PRESS RELEASE FROM MARKETWIRE Spectral Announces Normal Course Issuer Bid Monday, July 04, 2016 Spectral Announces Normal Course Issuer Bid...
Compassionate use is AMAZING NEWS!!! This is big:D
FDA Accepts Spectral’s Expanded Access Protocol for ToraymyxinTM ToraymyxinTM may now be used at hospitals that participated in EUPHRATES trial...
No coverage on BNN Market call, probably because the guest said they don't buy phase III companies.... great news that the trial enrolment has...
May 31, 2016 08:00 ET Spectral Medical Files Expanded Access Protocol With FDA for Toraymyxin™ Septic Shock Treatment Four patients remaining to...
Spectral Investor Presentation March 2016. Highlights: Sepsis: A Significant Unmet Medical Need - Common: >30% of ICU admissions - Extremely...
Marketwire - Canada Published May 12, 2016 TORONTO, ONTARIO--(Marketwired - May 12, 2016) - Spectral Medical Inc., (TSX:EDT) (OTCQX:EDTXF), a...
Spectral Commends Inclusion Of Organ Dysfunction In New Expert Consensus Definitions Of Sepsis And Septic Shock New sepsis definitions align with...
Latest Press Release: CORRECTION FROM SOURCE: Spectral Announces Fourth Quarter and Fiscal 2015 Results T.EDT | 1 day ago TORONTO,...
Link to company website : http://www.spectraldx.com Link to Yahoo Finance site: https://au.finance.yahoo.com/q?p=finance.yahoo.com&s=EDT.TO&ql=0
About Spectral: Spectral Medical Inc. (TSX:EDT / OTC:EDTXF) is Toronto-based pharmaceutical company enrolling the final 75 patients into the only...
